Takeda Pharmaceutical (TAK) EPS (Diluted) Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) EPS (Diluted) Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.77 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.87 Bn | 30.20 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.98 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.27 Bn | 19.60 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.81 Bn | 17.93 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.69 Bn | 15.30 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 12.13 Bn | 11.60 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.17 Bn | 10.01 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -87.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.66% |
| Mar 31, 2026 | -0.19% |
| Dec 31, 2025 | -68.62% |
| Sep 30, 2025 | 47.58% |
| Jun 30, 2025 | 0.79% |
| Mar 31, 2025 | 116.75% |
| Dec 31, 2024 | -49.14% |
| Sep 30, 2024 | 49.62% |
| Jun 30, 2024 | -21.45% |
| Mar 31, 2024 | -29.97% |
| Dec 31, 2023 | -38.15% |
| Sep 30, 2023 | 273.40% |
| Jun 30, 2023 | -5.24% |
| Mar 31, 2023 | 268.44% |
| Sep 30, 2022 | -10.89% |
| Jun 30, 2022 | -76.64% |
| Mar 31, 2022 | 39.13% |
| Dec 31, 2021 | -4.04% |
| Sep 30, 2021 | 78,144.20% |
| Jun 30, 2021 | -4.34% |